David Juurlink, MD PhD

Scientist,
Institute for Clinical Evaluative Sciences (ICES),
Sunnybrook Health Sciences Centre

David Juurlink is Assistant Professor in the Department of Medicine at the University of Toronto, staff physician in the Divisions of General Internal Medicine and Clinical Pharmacology at Sunnybrook Health Sciences Centre, and a Scientist at the Institute for Clinical Evaluative Sciences (ICES).

His areas of expertise include pharmacy, internal medicine, clinical pharmacology and toxicology and clinical epidemiology. His contribution to this project primarily involves aspects of clinical pharmacology and health services research. He is also interested in clinical epidemiology and health services research. Since 2001, Juurlink has been involved in numerous drug safety studies using administrative databases, including OHIP, CIHI, and ODB databases.

Selected Publications

  • Sivilotti ML, Good AM, Yarema MC, Juurlink DN, Johnson DW. A new predictor of toxicity following acetaminophen overdose based on pretreatment exposure. Clinical Toxicology (Philadelphia, Pa.). 2005; 43(4):229-34.
  • Nagge JJ, Knowles SR, Juurlink DN, Shear NH. Pseudoephedrine-induced toxic epidermal necrolysis. Archives of Dermatology. 2005; 141(7):907-8.
  • Juurlink DN. Celecoxib increased cardiovascular events in patients with colorectal adenomas. ACP Journal Club. 2005; 143(1):3.
  • Sivilotti ML, Juurlink DN, Burns MJ. Withholding 4-methylpyrazole pretreatment in suspected toxic alcohol ingestions. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine. 2005; 12(6):574-5.
  • Garg AX, Mamdani M, Juurlink DN, van Walraven C, Network of Eastern Ontario Medical Laboratories (NEO-MeL). Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance. Journal of the American Society of Nephrology. 2005; 16(5):1433-9.

See publications by David Juurlink on PubMed.